Stay updated with breaking news from Emyria Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emyria Ltd (ASX:EMD), a mental health and neurologically focused biotechnology company developing a cutting-edge MDMA-assisted therapy model, has had a busy...
Emyria Ltd (ASX:EMD) MD Michael Winlo introduces Proactive to the company’s new independent non-executive chairman Greg Hutchinson. Hutchinson will help...
Australian shares are down a fraction today, just 4.60 points, to 7,073.60 The local bourse has lost 0.45% for the last five days but is virtually unchanged...
It’s been a difficult quarter for the biotech sector, with economies struggling to recover from high inflation making for a small appetite for risk. The ASX...
The cannabis industry has seen a significant surge in popularity in the last 10 years, leading to enhanced transparency, market understanding and growing...